A Study of ABBV-181 in Participants With Advanced Solid Tumors

Condition:   Advanced Solid Tumors
Interventions:   Drug: ABBV-181;   Drug: Rovalpituzumab Tesirine
Sponsor:   AbbVie
Recruiting - verified July 2017

http://ift.tt/2uaNqo4